Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies

About this study

Last updated on

This study is for people with:Multiple Sclerosis
Intervention being studied:other disease-modifying therapy, Fingolimod (drug)
Sponsored by:Novartis Pharmaceuticals
Number of participants:3620 participants
Unique study IDNCT01442194

How to apply

Find a study site convenient for you below, then email yourself the contact details and next steps.

Choose a site

Participation requirements

Open toboth females and males

There are 226 locations for this study